Richman Michael bought NXTC
January 30, 2026 · Form 4 insider transaction
Richman Michael bought 38,190 shares of NextCure, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
38,190
Price
$0.00
Total value
N/A
InsiderRichman Michael
RoleOfficer, Director
CompanyNextCure, Inc. (NXTC)
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 3, 2026
Shares owned after38,190
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One fourth of the option vests on January 30, 2027. The remainder vests in 36 monthly installments beginning on February 28, 2027.